-
-
Call more information
660-596-2224 -
Authors: Basem B. Abdelmalak, MD, FASA, SAMBA-F et al ASA Monitor November 2022, Vol. 86, 26–27. Driven by advances in minimally invasive diagnostic and therapeutic procedures, the demand for anesthesia and procedural sedation outside the OR has expanded more rapidly than ever. This has placed tremendous strain on anesthesiology departments, both to fulfill anesthesia service needs […]
Read MoreASA Monitor October 2022, Vol. 86, 16. Which of the following agents is MOST likely to decrease intraocular pressure? □ (A) Fentanyl □ (B) Succinylcholine □ (C) Midazolam Ophthalmic surgeries are the most commonly performed surgical procedures in the United States. Intraocular pressure (IOP) is defined by the pressure exerted by different components of the globe to the containing […]
Read MoreAuthor: Amy Gallagher ASA Monitor November 2022, Vol. 86, 16. Accepting and adapting to change is a function of growth and development, which is a critical factor in the complex and fast-growing pursuit of personalized medicine. As a clinical pharmacologist, Robert L. Barkin, MBA, PharmD, FCP, OFRSM, has been involved in pain management for decades. Barkin […]
Read MoreAuthors: Richard Simoneaux; Steven L. Shafer, MD, FASA ASA Monitor October 2022, Vol. 86, 1–8. In 2012, the Nobel Prize in Chemistry was awarded to Robert J. Lefkowitz, Howard Hughes Medical Institute/Duke University Medical Center, and Brian K. Kobilka, Stanford University School of Medicine, for “groundbreaking discoveries that reveal the inner workings of… G-protein-coupled receptors” (asamonitor.pub/3Cb1vVL). G-protein-coupled […]
Read MoreAuthors: Richard P. Dutton, MD, MBA, FASA et al ASA Monitor November 2022, Vol. 86, 21–22. Most hospitals in America are seeking an increase in anesthesia services, mainly due to increasing need for nonoperating room coverage. At present, the market demand for anesthesia clinicians exceeds the available supply by a substantial margin. Among the possible solutions […]
Read More